Status and phase
Conditions
Treatments
About
The purpose of this phase Ⅰ study is to evaluate the safety, tolerability and pharmacokinetics of HRS-1893 in healthy volunteers and patients with obstructive hypertrophic cardiomyopathy
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
76 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Sheng Qi; Xiaoyi Sun
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal